Kramarz P - Search Results

1

Pandemic influenza A(H1N1) 2009 vaccines in the European Union.

Johansen K, Nicoll A, Ciancio BC, Kramarz P. Johansen K, et al. Among authors: kramarz p. Euro Surveill. 2009 Oct 15;14(41):19361. Euro Surveill. 2009. PMID: 19883538 Free article.

2

Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications.

Nicoll A, Ciancio B, Kramarz P; Influenza Project Team. Nicoll A, et al. Among authors: kramarz p. Euro Surveill. 2008 Jan 31;13(5):8025. doi: 10.2807/ese.13.05.08025-en. Euro Surveill. 2008. PMID: 18445376 Free article.

3

Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.

Kramarz P, Monnet D, Nicoll A, Yilmaz C, Ciancio B. Kramarz P, et al. Euro Surveill. 2009 Feb 5;14(5):19112. doi: 10.2807/ese.14.05.19112-en. Euro Surveill. 2009. PMID: 19215715 Free article.

4

Initial epidemiological findings in the European Union following the declaration of pandemic alert level 5 due to influenza A (H1N1).

ECDC Technical Emergency Team. ECDC Technical Emergency Team. Euro Surveill. 2009 May 7;14(18):19204. doi: 10.2807/ese.14.18.19204-en. Euro Surveill. 2009. PMID: 19422780 Free article.

5

Seasonal and pandemic influenza vaccines for the elderly and other risk groups: a review of available data.

Kramarz P, Ciancio B, Nicoll A. Kramarz P, et al. Pol Arch Med Wewn. 2009 Oct;119(10):654-9. Pol Arch Med Wewn. 2009. PMID: 19847142 Free article. Review.

6

Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses.

Ciancio BC, Meerhoff TJ, Kramarz P, Bonmarin I, Borgen K, Boucher CA, Buchholz U, Buda S, Dijkstra F, Dudman S, Duwe S, Hauge SH, Hungnes O, Meijer A, Mossong J, Paget WJ, Phin N, van der Sande M, Schweiger B, Nicoll A. Ciancio BC, et al. Among authors: kramarz p. Euro Surveill. 2009 Nov 19;14(46):19412. Euro Surveill. 2009. PMID: 19941797 Free article.

7

Experience and lessons from surveillance and studies of the 2009 pandemic in Europe.

Nicoll A, Ammon A, Amato Gauci A, Ciancio B, Zucs P, Devaux I, Plata F, Mazick A, Mølbak K, Asikainen T, Kramarz P. Nicoll A, et al. Among authors: kramarz p. Public Health. 2010 Jan;124(1):14-23. doi: 10.1016/j.puhe.2009.12.001. Public Health. 2010. PMID: 20141821

8

Monitoring and assessing vaccine safety: a European perspective.

Lopalco PL, Johansen K, Ciancio B, De Carvalho Gomes H, Kramarz P, Giesecke J. Lopalco PL, et al. Among authors: kramarz p. Expert Rev Vaccines. 2010 Apr;9(4):371-80. doi: 10.1586/erv.10.20. Expert Rev Vaccines. 2010. PMID: 20370548 Review.

9

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.

Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, Nunes B, Pitigoi D, Larrauri Cámara A, Mosnier A, Horvath JK, O'Donnell J, Bella A, Guiomar R, Lupulescu E, Savulescu C, Ciancio BC, Kramarz P, Moren A. Valenciano M, et al. Among authors: kramarz p. PLoS Med. 2011 Jan;8(1):e1000388. doi: 10.1371/journal.pmed.1000388. Epub 2011 Jan 11. PLoS Med. 2011. PMID: 21379316 Free PMC article.

10

Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.

Kissling E, Valenciano M; I-MOVE case-control studies team. Kissling E, et al. Euro Surveill. 2011 Mar 17;16(11):19818. doi: 10.2807/ese.16.11.19818-en. Euro Surveill. 2011. PMID: 21435329 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters